$ Value
—
Shares
95,520
Price
—
Filed
Dec 12
Insider
Name
Schamis David Ira
Title
Chief Executive Officer
CIK
0001377409
Roles
Transaction Details
Transaction Date
2025-12-04
Code
J
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
95,520
Footnotes
On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 95,520 shares of Common Stock to Mr. Schamis, a member of Rorschach Capital LLC.
Filing Info
Other Insiders at PURR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LEIBOWITZ LAWRENCE E | — | — | 2026-04-01 |
|
Schamis David Ira
CEO
|
— | — | 2026-02-09 |
| Diamond Robert E. Jr. | — | — | 2026-02-09 |
| Dyrness Albert D. | — | — | 2026-02-09 |
| TUDER JEFFREY | — | — | 2026-02-09 |
| KING THOMAS C. | — | — | 2026-04-01 |
| Bhatt Nailesh | — | — | 2026-04-01 |
| Rosengren Eric S | — | — | 2026-04-01 |